Technology Introduction:
This project defines "Sng" as a novel somatosensory modality distinct from pain. By integrating molecular neurobiology, clinical diagnosis, linguistic corpus studies, AI behavioral analysis, and precision therapies, the project develops dedicated diagnostic scales and multimodal interventions, improving identification and treatment of chronic sng-pain while also enhancing intercultural medical communication and advancing outcomes in global healthcare.
Industry Applicability:
This technology integrates clinical and fundamental research, enabling widespread adoption of the sng assessment scale across healthcare institutions and advancing personalized care and precision medicine. AI systems support both patient diagnostics and animal model evaluations, improving accuracy and accelerating therapeutic validation. In parallel, linguistic corpus analysis enhances intercultural medical communication by clarifying how pain descriptors vary across languages, thereby fostering international collaboration in biomedical practice. This dual focus—scientific rigor in neurobiology and cultural insight in linguistics—strengthens Taiwan’s competitive advantage, expanding industry-academia cooperation and setting a global benchmark in the research, diagnosis, and treatment of chronic sng-pain.